TrialClinical rheumatology2015

Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice.

Vivian P Bykerk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.